Collagen/chitosan hybrid 3D-scaffolds as potential biomaterials for tissue engineering Online publication date: Thu, 23-Aug-2018
by Hilary Ureña-Saborio; Emilia Alfaro-Viquez; Daniel Esquivel-Alvarado; Marianelly Esquivel; Sergio Madrigal-Carballo
International Journal of Nano and Biomaterials (IJNBM), Vol. 7, No. 3, 2018
Abstract: Chitosan (CHT) has been reported to be biocompatible, bio-absorbable and particularly, is considered a good wound-healing accelerator. On the other hand, collagen (CGN) is one of the most widely used matrix biomaterial in tissue engineering. Highly porous CGN single 3D-scaffolds have been used to support in vitro growth of many types of tissues. We fabricated hybrid 3D-scaffold biomaterials by mixing CHT from native shrimp waste streams and CGN from tilapia aquaculture waste by-products, applying previously developed methodologies involving solvent casting and freeze-drying. CGN/CHT hybrid 3D-scaffolds were characterised according to its water uptake capacity, mechanical properties, thermal behaviour (TGA), and morphology (SEM). Hybrid 3D-scaffolds showed improved stability, greater porosity, increased thermal stability and mechanical properties, as well higher biodegradation as compared to single 3D-scaffolds. Cell culture incubation with adipose tissue-derived stem cell (ADSC) and SEM imaging showed that CGN/CHT hybrid 3D-scaffolds allowed ADSC adhering, spreading, and growing in vitro.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nano and Biomaterials (IJNBM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com